
- Published 2026
- No of Pages: 120+
- 20% Customization available
Advanced Pellicles for EUV and DUV Lithography Market | Size, Growth Forecast, Market Share
Market Summary and Growth Forecast
The global Advanced Pellicles for EUV and DUV Lithography Market is valued at $1,460 million in 2026 and is expected to appreciate to $4,120 million by 2035, at a CAGR of 12.2%.
Pellicles are ultra-thin protective membranes mounted above semiconductor photomasks. They prevent airborne particles from settling directly on the patterned mask surface. Particles collected on the pellicle remain outside the scanner’s focal plane and are less likely to print as defects on the wafer.
This function becomes commercially important when a single contaminated reticle can interrupt a high-value production line, lower wafer yield, and require additional mask inspection or cleaning. For leading-edge logic and memory manufacturers, pellicles are therefore not simple protective films. They are yield-management and equipment-productivity components.
“EUV lithography expansion is increasing pressure on semiconductor fabs to maintain cleaner and more stable mask environments during exposure processes. This keeps Advanced Pellicles for EUV and DUV Lithography closely connected with Photomasks and Reticles for Semiconductor Lithography, where pellicles help reduce contamination-related yield losses. The market also overlaps with Critical dimension measurement tools for Semiconductor Industry used for advanced lithography verification. Rising EUV process complexity is additionally strengthening alignment with Photoresists and Ancillary Chemicals for Semiconductor Manufacturing. “
The Advanced Pellicles for EUV and DUV Lithography Market covers high-transmission pellicles used with:
- Extreme ultraviolet lithography at 13.5 nanometers
- ArF immersion and ArF dry lithography at 193 nanometers
- KrF lithography at 248 nanometers
- Selected advanced i-line and specialty lithography processes
- Conventional and High-NA EUV exposure platforms
The forecast represents an original bottom-up estimate. It considers the active lithography-tool base, new scanner deliveries, mask consumption, pellicle replacement frequency, higher pellicle value at EUV wavelengths, and the transition from silicon-based EUV membranes to carbon nanotube structures.
Global Market Outlook
| Market Indicator | Estimate |
| Market size, 2026 | $1,460 million |
| Forecast market size, 2030 | $2,360 million |
| Forecast market size, 2035 | $4,120 million |
| CAGR, 2026–2035 | 12.2% |
| Principal growth engine | High-volume EUV adoption |
| Fastest-developing technology | Carbon nanotube EUV pellicles |
| Largest consuming region | Asia Pacific |
| Primary demand base | Semiconductor foundries and integrated device manufacturers |
The market has two different growth profiles.
Advanced DUV pellicles form the established volume base. They are used across logic, memory, power, image sensor, connectivity, automotive, and industrial semiconductor production. Even advanced chips produced with EUV continue to require numerous DUV lithography steps. So, EUV does not fully replace DUV pellicle consumption.
EUV pellicles form the faster-growing value pool. They require exceptionally thin membranes because most materials absorb 13.5-nanometer radiation. The membrane must transmit enough EUV energy while tolerating intense heat, hydrogen exposure, repeated scanner cycles, vibration, pressure changes, and handling stress.
The commercial relevance of this challenge is increasing. ASML reported sales of 48 EUV lithography systems and 279 DUV systems in 2025. This expanding installed base creates recurring demand for compatible masks, pellicles, inspection systems, replacement materials, and technical services.
Also, global 300-millimeter fab equipment expenditure is projected at $133 billion in 2026, representing an 18% annual increase. The spending cycle is being supported by AI processors, high-bandwidth memory, advanced packaging, regional supply-chain programs, and new logic capacity.
Core Growth Forces, 2026–2035
- Expansion of EUV exposure steps
The number of EUV layers per advanced device is increasing as manufacturers move from 5-nanometer and 3-nanometer processes toward 2-nanometer, A14-class, and future nodes. More EUV layers require additional reticles, greater mask utilization, and stronger contamination control.
TSMC started volume production of its 2-nanometer process in the fourth quarter of 2025. It is also researching new mask pellicles and blanks while developing lithography processes for High-NA EUV scanners.
- Transition to higher scanner power
EUV source power is moving toward 600 watts and above. Higher output improves scanner productivity, but it creates greater thermal stress on the pellicle. Existing silicon-based membranes face limits involving heat resistance, transmission, oxidation, deformation, and lifetime.
This is pushing the industry toward carbon nanotube membranes. Mitsui Chemicals is developing CNT pellicles with transmission of at least 92% and resistance to exposure output above 1 kilowatt.
- Introduction of High-NA EUV
High-NA EUV uses a 0.55 numerical aperture, compared with 0.33 for the established EUV platform. It supports finer patterning, but also raises requirements for reticle quality, thermal stability, membrane uniformity, contamination control, and defect inspection.
The first full-specification commercial High-NA platform was delivered during 2025, while major logic and memory producers are preparing development and manufacturing lines around the technology.
Growth in advanced logic and memory capacity
AI accelerators, data-center processors, high-bandwidth memory, smartphones, and edge-computing devices require high transistor density and greater lithography intensity. SEMI expects advanced chipmaking capacity to rise by approximately 69% between the end of 2024 and 2028, reaching 11.1 million 300-millimeter wafers per month.
This does not mean pellicle demand rises at the same rate. Pellicle lifetime, mask utilization, fab productivity, and customer qualification also matter. Still, the direction is structural rather than cyclical.
- Localization and supply security
Pellicle supply is highly concentrated. Qualification may take several years because membrane failure can damage throughput and compromise expensive masks. Foundries therefore prefer proven suppliers with strong quality systems, stable raw-material access, and close relationships with scanner and mask manufacturers.
Regional fab construction in the United States, Japan, South Korea, Taiwan, and Europe may encourage local inspection, assembly, technical support, and inventory infrastructure. Core membrane know-how, however, is likely to remain concentrated among a small number of companies through the forecast period.
Formal environmental regulation is not the main market determinant. Customer qualification, export-control compliance, material purity, intellectual-property access, and supply-chain traceability are more influential.
Key Consumers and Commercial Clients
The principal buyers and technical users include:
- Pure-play foundries such as TSMC, Samsung Foundry, GlobalFoundries and United Microelectronics Corporation
- Integrated logic manufacturers such as Intel
- Memory producers such as Samsung Electronics, SK hynix and Micron Technology
- Emerging advanced-node manufacturers such as Rapidus
- Photomask suppliers such as Dai Nippon Printing, Toppan Photomask and Photronics
- Lithography and process-development organizations such as ASML and imec
- Captive mask shops operated by large semiconductor manufacturers
Purchasing arrangements differ by company. In some cases, the wafer manufacturer controls pellicle qualification directly. In others, procurement involves the photomask producer, lithography-equipment company, membrane supplier, frame assembler, and inspection partner.
Expert view: Pellicle spending will remain small compared with the cost of a lithography scanner or semiconductor fab. Its economic value is much larger than its procurement value, however, because one qualified pellicle can protect reticle integrity, scanner uptime, and the yield of thousands of wafers.
Market Segmentation and Forecast Scope
The Advanced Pellicles for EUV and DUV Lithography Market can be segmented by exposure technology, membrane material, semiconductor application, end-user category, and region. Each dimension captures a different commercial issue. Exposure technology determines performance requirements. Application influences mask intensity. End users determine qualification cycles. Region reflects where wafer fabrication and mask infrastructure are concentrated.
By Product Type
EUV Pellicles
EUV pellicles are used with 13.5-nanometer lithography systems. They require exceptionally high transmission and thermal stability. Their technical specifications are considerably more demanding than those of DUV pellicles.
EUV products account for an estimated 56.2% of global market revenue in 2026. Their revenue share is larger than their unit share because EUV pellicles have higher material, manufacturing, testing, and qualification costs.
This category includes:
- Silicon-based EUV pellicles
- Composite EUV membranes
- Carbon nanotube EUV pellicles
- Pellicle frames and mounting assemblies
- Coated or chemically stabilized membranes
- High-power and High-NA-compatible products
Carbon nanotube pellicles are the most strategic sub-segment. They offer higher transmission, improved thermal endurance, low reflectance, and greater suitability for high-output scanners. Commercial adoption will depend on defect control, membrane lifetime, production yield, inspection capability, and final customer qualification.
DUV Pellicles
DUV pellicles remain the volume foundation of the industry. They protect masks used in ArF immersion, ArF dry, KrF, and selected older lithography processes.
The segment is mature, but not obsolete. A leading-edge semiconductor may use EUV for its most critical layers while relying on DUV for many additional patterning steps. DUV demand is also supported by mature-node capacity for automotive chips, power-management devices, analog semiconductors, microcontrollers, connectivity components, sensors, and display drivers.
ArF immersion pellicles represent the most technically demanding part of the DUV category. Suppliers compete on optical transmission, chemical resistance, film uniformity, frame precision, adhesive stability, outgassing, and usable lifetime.
By Membrane Material
Silicon-Based Membranes
Silicon-based materials supported the first commercially available EUV pellicles. They provide a qualified reference platform and benefit from established production experience.
Their main constraint is the balance between transmission and durability. A thinner membrane improves EUV transmission but may weaken mechanical and thermal stability. A thicker structure improves strength but absorbs more radiation.
Carbon Nanotube Membranes
CNT membranes consist of interconnected nanoscale carbon structures. Their open network allows high EUV transmission while supporting heat dissipation and mechanical strength.
imec and Mitsui Chemicals have reported jointly developed CNT pellicles with EUV transmission of at least 94% and resistance to power levels above 1 kilowatt.
This is forecast to be the fastest-growing material category. Adoption will move through pilot production, risk production, and customer-specific high-volume qualification rather than a single industry-wide conversion.
Fluoropolymer and Other DUV Films
Advanced DUV pellicles use optical polymer films selected for their compatibility with ArF, KrF, and other exposure wavelengths. Film formulation must limit absorption, haze formation, chemical degradation, and dimensional change.
Innovation in this category is more incremental. Suppliers focus on longer life, fewer replacement events, lower outgassing, and compatibility with increasingly stringent mask-cleaning and scanner conditions.
Graphene and Other Experimental Materials
Graphene, nanotube hybrids, and other two-dimensional materials remain under evaluation. They offer theoretical advantages in transmission and strength, but large-area uniformity, defect-free transfer, frame attachment, and repeatable manufacturing remain difficult.
These materials form a longer-term option rather than the central 2026 revenue base.
By Application
Advanced Logic Manufacturing
This segment includes processors, AI accelerators, smartphone systems-on-chip, graphics processors, networking devices, and high-performance computing products.
It is the main commercial driver for EUV pellicles. Leading logic processes use a growing number of EUV layers. They also carry high wafer values, so yield losses caused by mask contamination are expensive.
Advanced logic is expected to remain the largest source of incremental market revenue through 2035.
DRAM Manufacturing
DRAM manufacturers are increasing EUV use to simplify multi-patterning and support smaller memory-cell dimensions. High-bandwidth memory demand adds further pressure to expand advanced DRAM capacity.
Memory pellicle demand can be highly sensitive to capital-spending cycles. That said, the long-term transition toward EUV-based DRAM patterning strengthens the segment’s strategic value.
NAND Flash Manufacturing
NAND producers have historically achieved density gains by adding vertical layers rather than relying mainly on lateral feature shrinkage. EUV adoption is therefore more limited than in advanced logic and DRAM.
DUV pellicles remain relevant across NAND lithography steps. Future EUV adoption may occur selectively where process complexity and overlay requirements justify the added cost.
Mature-Node and Specialty Semiconductor Manufacturing
This category includes automotive, analog, power-management, radio-frequency, sensor, microcontroller, and industrial devices.
Most demand is linked to DUV lithography. Growth is slower than advanced EUV demand, but the installed fab base is large. Replacement consumption and new regional mature-node capacity provide a stable revenue stream.
Lithography Research and Process Development
Research institutes, mask-development centers, scanner manufacturers, and semiconductor R&D lines purchase small quantities of technically advanced pellicles.
Unit volumes are limited. However, this segment plays an important role in qualifying new materials and defining requirements that later move into volume manufacturing.
By End User
Pure-Play Foundries
Foundries serve multiple chip-design customers and operate large mask libraries. They require strict contamination control because a defect may affect several customer products and production lots.
Foundries are the most strategic end-user category due to their advanced-node exposure volume, mask diversity, and influence over supplier qualification.
Integrated Device Manufacturers
IDMs design and manufacture their own logic, memory, analog, or specialty semiconductors. Their requirements vary widely.
Advanced IDMs often work directly with lithography-equipment suppliers, mask shops, and material companies. Memory IDMs may place greater emphasis on throughput, pellicle lifetime, and cost per wafer.
Merchant and Captive Photomask Manufacturers
Mask manufacturers may procure pellicles, mount them on completed reticles, inspect the full assembly, and supply the protected mask to a semiconductor customer.
The shift toward EUV raises their need for cleaner assembly environments, more sensitive inspection tools, automated handling, and stronger traceability.
Research Institutes and Equipment Developers
Organizations such as imec, ASML, national laboratories, and university-linked semiconductor centers evaluate experimental membrane structures and exposure performance.
Their commercial volumes are small, but their validation work can determine whether a material becomes acceptable for future scanners.
By Region
Asia Pacific
Asia Pacific holds an estimated 79.1% share in 2026. The region contains the largest concentration of advanced foundries, memory fabs, photomask production sites, and pellicle manufacturers.
Taiwan and South Korea lead consumption. Japan is central to pellicle materials, photomasks, equipment components, and semiconductor chemicals. China provides substantial DUV demand through mature-node and expanding 300-millimeter capacity.
Asia Pacific will retain market leadership through 2035, although new fabs elsewhere will gradually reduce its concentration.
North America
North American demand is led by advanced logic development, memory manufacturing, mask operations, and High-NA EUV deployment.
The United States is expected to gain share as new fabs enter production and domestic advanced-node capacity expands. The region also plays a major role in early High-NA qualification.
Europe
Europe is smaller in direct wafer-fab consumption but strategically important to the supply chain.
The region includes ASML, imec, major optical and metrology capabilities, and Canatu’s CNT technology platform. European activity is concentrated in lithography development, equipment engineering, advanced materials, automotive semiconductors, and research.
Latin America, Middle East and Africa
The LAMEA market remains limited. Consumption is mainly associated with smaller semiconductor operations, research institutions, mask services, and imported lithography infrastructure.
Material expansion before 2035 would require major wafer-fab investment and the creation of local mask, inspection, and contamination-control capabilities.
Expert view: The most important segmentation shift is not the simple substitution of DUV by EUV. It is the emergence of a two-speed market—stable, high-volume DUV consumption alongside high-value EUV pellicles that require much deeper cooperation among membrane suppliers, mask makers, scanner companies, and wafer manufacturers.
Market Trends and Business Innovations
Innovation in the Advanced Pellicles for EUV and DUV Lithography Market is moving from basic membrane feasibility toward manufacturability, lifetime, inspection, and cost per exposed wafer.
Earlier EUV development focused on proving that an ultra-thin membrane could survive inside the scanner. The commercial question has now changed. Semiconductor manufacturers need pellicles that can be produced repeatedly, mounted without damage, inspected for nanoscale defects, operated under rising source power, and replaced at a predictable interval.
R&D Evolution: From Feasibility to Production Economics
The first generation of commercial EUV pellicles demonstrated that mask protection was possible at the 13.5-nanometer wavelength. Current R&D is more focused on five measurable targets:
- Higher EUV transmission
- Greater thermal endurance
- Longer operating life
- Lower defect density
- Repeatable high-volume production
A gain of several percentage points in membrane transmission can have substantial economic value. Less EUV energy is absorbed by the membrane, allowing more light to reach the mask and wafer. This can increase scanner throughput or reduce the power required for a given exposure.
Canatu estimates that advanced CNT membranes could support an 8% to 15% productivity improvement in the EUV lithography process compared with conventional composite structures.
Expert view: Pellicle competition will increasingly be measured in wafers processed before replacement, not only in headline transmission. A highly transparent membrane that fails early may have less economic value than a slightly lower-transmission product with predictable lifetime and stronger manufacturing yield.
Technology Evolution Toward Carbon Nanotubes
Carbon nanotubes have become the leading candidate for next-generation EUV pellicles.
The membrane uses a thin, porous CNT network rather than a continuous silicon film. This structure combines high transmission with strong heat tolerance. It may therefore support the transition from current EUV source power to systems operating at 600 watts or more.
In May 2024, Mitsui Chemicals announced a dedicated CNT pellicle manufacturing facility at its Iwakuni-Ohtake Works. The facility was designed for annual capacity of 5,000 sheets, with construction scheduled for completion in December 2025. The targeted product specification includes at least 92% EUV transmission and resistance above 1 kilowatt.
This capacity is small compared with conventional film manufacturing. Yet pellicles are high-value, low-volume precision components. A few thousand qualified units can support meaningful exposure capacity, depending on pellicle lifetime, mask utilization, and fab operating conditions.
High-NA EUV Changes the Design Envelope
High-NA EUV will not merely require a stronger version of the same pellicle. The technology changes the operating and optical environment.
The higher numerical aperture supports smaller features, but it also increases sensitivity to mask properties, field configuration, thermal distortion, and optical uniformity. Pellicle developers must control:
- Membrane flatness
- Local transmission variation
- Reflectance
- Mechanical sag
- Thermal expansion
- Frame distortion
- Particle shedding
- Hydrogen-induced degradation
High-NA systems are also associated with expensive masks and limited initial production capacity. This raises the value of contamination protection, but it also increases the cost of qualification failure.
Intel installed the first commercial High-NA EUV system and has proceeded with the acceptance of the higher-throughput EXE:5200B platform. The system targets throughput of up to 175 wafers per hour, creating stronger demand for pellicles that can maintain performance under sustained exposure.
Material Science and Surface Engineering
Membrane material receives most industry attention, but the pellicle is a complete assembly. Its commercial performance also depends on the frame, bonding method, coatings, handling system, and cleanliness of assembly.
Key material-science developments include:
Thermal-emissivity enhancement
Pellicles absorb part of the incident EUV energy. Surface treatments and material architecture are being developed to release heat more efficiently and reduce thermal deformation.
Oxidation and hydrogen resistance
The EUV scanner environment includes hydrogen, plasma-related species, and reactive contaminants. Long-term exposure may alter membrane properties. Protective coatings must improve durability without materially reducing transmission.
Low-outgassing adhesives and frames
Materials used to attach the membrane to the frame must remain stable under vacuum and repeated thermal cycling. Outgassing can contaminate scanner optics or mask surfaces.
Defect-controlled CNT deposition
CNT performance depends on network density, tube quality, membrane thickness, and uniformity across a large area. Small variations can affect transmission, strength, and heat distribution.
The manufacturing challenge is therefore not producing carbon nanotubes alone. It is creating a defect-controlled membrane with repeatable optical and mechanical properties.
Inspection and Metrology Become Commercial Bottlenecks
A pellicle may appear intact at normal visual resolution while containing pinholes, wrinkles, contamination, thickness variation, or weak attachment points.
Advanced production requires dedicated inspection before membrane mounting, after assembly, and sometimes after use. Metrology systems must distinguish harmless features from defects that could propagate or affect imaging.
During 2025, Canatu ordered a specialized pellicle inspection platform from Lasertec to strengthen its quality-control and metrology capability. This illustrates how equipment investment is moving beyond membrane deposition into end-to-end product validation.
Automated image analysis and statistical process control will become more important as production scales. AI is not yet a defining feature of the pellicle itself. Its practical role lies in defect classification, pattern recognition, process drift detection, and inspection-data analysis.
A New Licensing and Recurring-Revenue Model
The conventional pellicle business relies mainly on selling finished assemblies. CNT commercialization is creating a second approach.
Technology developers may sell deposition reactors, license production know-how, provide proprietary consumables, and receive royalties on each pellicle sold. This allows manufacturing to take place close to customers while the technology owner retains recurring economic participation.
In July 2025, Canatu’s first CNT100 SEMI reactor passed site-acceptance testing at a semiconductor customer. The approval confirmed that the system was ready for CNT pellicle membrane mass production, subject to final qualification of the completed pellicle and manufacturing line.
In October 2025, Canatu granted Fine Semitech Corporation a commercial license to mass-produce CNT pellicle membranes. The agreement created three potential revenue streams: an initial license fee, recurring consumable sales, and royalties on pellicles sold.
This model may lower the need to ship highly fragile membranes across long distances. It also supports local production near major semiconductor clusters.
Partnerships, Consolidation and Recent Announcements
| Date | Organizations | Development | Business Significance |
| December 2023 | imec and Mitsui Chemicals | Strategic partnership to commercialize CNT pellicles | Combines scanner validation and materials-manufacturing capability |
| May 2024 | Mitsui Chemicals | Announced a 5,000-sheet annual CNT pellicle facility | Establishes dedicated capacity for high-power and High-NA applications |
| December 2024 | Canatu and an undisclosed semiconductor customer | Delivery of a second CNT membrane-production reactor | Demonstrates demand for customer-side manufacturing infrastructure |
| July 2025 | Canatu and Fine Semitech Corporation | Reactor and post-processing equipment passed site acceptance | Moves CNT technology closer to pilot and risk production |
| October 2025 | Canatu and Fine Semitech Corporation | Commercial production license granted | Introduces royalties and consumable-based recurring revenue |
| 2025 | ASML and leading chip manufacturers | First full-specification EXE:5200B delivery | Accelerates requirements for High-NA-compatible mask protection |
The partnership between imec and Mitsui Chemicals targets CNT pellicles with at least 94% transmission and power endurance beyond 1 kilowatt. Their development roadmap links pellicle introduction with advanced logic nodes beyond 2 nanometers and higher-output EUV scanners.
Consolidation is also shaping the supplier base. Mitsui Chemicals acquired the pellicle operations of Asahi Kasei, combining semiconductor and display-pellicle manufacturing capabilities. The transferred business began operating through Mitsui Chemicals EMS in July 2023.
This consolidation provides broader production infrastructure and customer access. It also raises entry barriers for smaller suppliers lacking qualified manufacturing lines, inspection capability, or long-term relationships with photomask customers.
DUV Innovation Remains Incremental but Commercially Important
DUV pellicle innovation receives less attention than EUV, but it remains relevant to the installed semiconductor base.
Current priorities include:
- Longer resistance to ArF exposure
- Reduced haze and crystal formation
- Greater compatibility with immersion processes
- Lower particle generation
- Improved frame dimensional stability
- Longer replacement intervals
- More automated mounting and inspection
The value proposition is based on reliability and cost per mask cycle rather than a complete material transition.
DUV pellicles are also benefiting from the geographic expansion of mature-node capacity. New automotive, analog, power, and industrial fabs require a dependable supply of qualified consumables even when their process technology is not at the leading edge.
Outlook for Innovation Through 2035
Between 2026 and 2030, the industry will focus on commercial CNT qualification, higher production yield, and integration with 600-watt-class EUV systems.
Between 2030 and 2035, development is expected to shift toward:
- Longer pellicle life under sustained high-power exposure
- High-NA-specific membrane and frame designs
- In-fab pellicle condition monitoring
- More localized licensed production
- Automated inspection and predictive replacement
- Lower cost per wafer exposure
- Greater standardization across masks and scanner platforms
Canatu estimates the EUV pellicle addressable market could reach approximately €1.5 billion in 2030. It expects advanced logic nodes and gate-all-around transistor processes to account for most of that opportunity.
Expert view: By 2035, the strongest suppliers may no longer define themselves as film manufacturers. They will operate as integrated contamination-control partners, combining membrane IP, deposition equipment, frames, inspection data, consumables, licensing, and lifecycle support.
The Advanced Pellicles for EUV and DUV Lithography Market will therefore become more technically concentrated even as demand expands. Revenue growth will favor suppliers that can convert laboratory-level transmission and durability into qualified, repeatable production.
Competitive Intelligence and Benchmarking
Competition in the Advanced Pellicles for EUV and DUV Lithography Market is concentrated across a small group of membrane manufacturers, lithography-material suppliers, equipment developers, and technology licensors. Entry barriers are unusually high. A supplier must demonstrate optical transmission, membrane uniformity, thermal endurance, particle control, frame stability, and repeatable production before a semiconductor customer begins commercial qualification.
The competitive structure differs between the two core product groups.
The DUV segment has an established supplier base, standardized applications, and a wider range of qualified products. Competition is based on membrane lifetime, wavelength compatibility, frame quality, production consistency, and price.
The EUV segment is more concentrated. Only a limited number of companies possess the material science, cleanroom infrastructure, scanner relationships, and inspection capabilities needed to support commercial production. Carbon nanotube pellicles are creating room for new participants, but the qualification process remains lengthy.
Competitive Benchmarking Table
| Company | Core Position | Portfolio Focus | Competitive Strength | Strategic Limitation |
| Mitsui Chemicals | Established EUV and DUV pellicle leader | Silicon-based EUV, CNT EUV and conventional lithography pellicles | Commercial EUV experience, ASML relationship and dedicated CNT capacity | High dependence on advanced-node qualification schedules |
| Shin-Etsu Chemical | Major DUV and semiconductor-material supplier | ArF, KrF and other optical pellicles | Integrated lithography-material portfolio and global customer access | Less visible commercial presence in next-generation EUV pellicles |
| Fine Semitech Corporation | South Korean pellicle specialist and emerging EUV challenger | DUV, display and developing CNT EUV pellicles | Proximity to major Korean semiconductor manufacturers and licensed CNT production | Commercial EUV scale remains under qualification |
| S&S Tech | Emerging South Korean EUV-material supplier | EUV pellicles, mask blanks and supporting components | Domestic semiconductor relationships and combined mask-material expertise | Lower commercial penetration outside South Korea |
| Canatu | CNT membrane technology and equipment provider | CNT membranes, deposition reactors, process licenses and consumables | Strong intellectual property position and scalable licensing model | Relies on manufacturing partners for completed pellicles |
| ASML | Lithography ecosystem gatekeeper | EUV pellicle technology, scanner integration and qualification support | Controls EUV scanner architecture and critical compatibility requirements | Does not operate as a broad independent merchant pellicle supplier |
| Micro Lithography, Inc. | Established conventional pellicle producer | DUV and mature-node photomask protection products | Large production history and broad conventional lithography experience | Limited public positioning in CNT and High-NA EUV products |
Mitsui Chemicals
Mitsui Chemicals holds the strongest established commercial position in EUV pellicles. Its portfolio spans conventional semiconductor pellicles, silicon-based EUV membranes, frames, and next-generation CNT structures.
The company became the first external pellicle manufacturer licensed to commercialize technology originally developed by ASML. This relationship gave it early access to EUV scanner requirements, mask specifications, and customer qualification processes.
Its main strategic move is the construction of a dedicated CNT pellicle production line in Japan. The facility is designed for 5,000 sheets annually and targets membranes with transmission of at least 92% and resistance to exposure power exceeding 1 kilowatt.
This positions Mitsui Chemicals across both the current and future technology cycles. It can continue serving established EUV platforms while preparing products for higher-power and High-NA exposure.
Its advantage is not based only on material performance. The company also possesses production infrastructure, application engineering, customer support, frame integration, and established quality systems.
Expert view: Mitsui Chemicals is likely to remain the reference commercial supplier during the early CNT transition. Its main risk is that licensed reactor-based production allows Korean or other Asian competitors to close the technology gap more quickly than expected.
Shin-Etsu Chemical
Shin-Etsu Chemical is a major supplier of pellicles for conventional semiconductor lithography. Its portfolio covers photomask protection for advanced optical processes, including ArF and KrF exposure.
The company benefits from a broader semiconductor-material platform that includes silicon wafers, photoresists, photomask substrates, quartz products, and other high-purity process materials. This allows it to work with semiconductor customers across several stages of the lithography value chain.
Its market strength is highest in DUV pellicles, where product quality, optical uniformity, and customer qualification history matter more than disruptive membrane design.
Shin-Etsu Chemical announced an investment of approximately ¥83 billion in a new Japanese production base for semiconductor lithography materials. The facility is intended to diversify manufacturing and respond to rising material demand, although the company has not publicly positioned the site as a dedicated EUV pellicle plant.
The company is strategically important because DUV exposure remains essential even in advanced fabs. A 2-nanometer chip may use EUV for critical layers while continuing to use ArF and other DUV processes for less demanding layers.
Fine Semitech Corporation
Fine Semitech Corporation, commonly referred to as FST, is one of South Korea’s principal pellicle suppliers. Its established activities include semiconductor and display pellicles, environmental-control equipment, and supporting inspection technologies.
Its strategic importance increased when Canatu granted it a commercial license to manufacture CNT pellicle membranes using the CNT100 SEMI reactor. Under the arrangement, FST operates the production equipment while paying a license fee, purchasing proprietary consumables, and potentially paying royalties on completed pellicles.
This gives FST a practical route into commercial EUV pellicles without developing the complete CNT deposition platform independently.
Its location is another advantage. South Korea contains large logic and memory manufacturing operations operated by Samsung Electronics and SK hynix. Local production may shorten development cycles, improve technical support, and reduce handling risks associated with transporting fragile membranes.
The key uncertainty is the timing of final scanner and customer certification. Reactor acceptance does not automatically mean that completed pellicles are approved for unrestricted high-volume use.
S&S Tech
S&S Tech is a South Korean supplier of photomask blanks and developing EUV pellicles. The company began its EUV pellicle program in 2016, followed by further investment in EUV mask-related products.
Its competitive model differs from that of a standalone membrane supplier. S&S Tech participates in both pellicle and mask-blank development. This may help the company optimize the interface between the photomask, protective membrane, frame, and inspection process.
The company is positioned as a technology challenger rather than a fully global commercial leader. Its most immediate market is South Korea, where government policy and semiconductor manufacturers have promoted localization of critical materials.
Its progress will depend on customer qualification, stable large-area membrane production, defect inspection, and performance under prolonged high-power exposure.
Canatu
Canatu is not primarily a conventional finished-pellicle manufacturer. It develops CNT membranes, deposition equipment, post-processing systems, production processes, and licensing arrangements.
Its CNT100 SEMI reactor allows customers to manufacture pellicle membranes internally or through licensed production partners. The first commercially licensed system is operated by FST.
This business structure creates three potential income streams:
- Reactor and supporting-equipment sales
- Recurring proprietary consumables
- Royalties linked to pellicle production
The approach is strategically relevant because pellicle membranes are delicate and technically difficult to ship. Local production near semiconductor customers may reduce logistics risk and allow closer integration with proprietary frame, coating, and inspection processes.
Canatu reported that the first customer-approved reactor was ready for CNT membrane mass production, although completed pellicles still require downstream qualification.
Its limitation is dependence on partners. The company may provide the membrane-production platform, but customer success also depends on mounting, inspection, scanner certification, and final fab approval.
ASML
ASML occupies a unique competitive position. It is not a conventional merchant pellicle supplier, but it remains the most influential company in the EUV pellicle ecosystem.
The company developed foundational EUV pellicle technology and transferred commercial manufacturing rights to Mitsui Chemicals. It also defines important scanner-interface requirements involving dimensions, thermal conditions, hydrogen exposure, handling, and optical performance.
Every commercial EUV pellicle must ultimately operate within an ASML lithography platform. So, scanner compatibility and certification create an indirect competitive barrier.
The introduction of High-NA systems increases this influence. Membrane and frame suppliers must align development with new scanner architectures, higher source power, and changing mask requirements.
Micro Lithography, Inc.
Micro Lithography, Inc. is an established supplier of conventional pellicles, with a production history exceeding 7 million units. Its products are primarily aligned with optical lithography and mature semiconductor processes.
The company’s strength is manufacturing experience. It understands frame assembly, film attachment, cleanliness, packaging, and customer-specific configurations across a broad range of conventional exposure systems.
Its position is more defensive than disruptive. Demand for mature-node DUV pellicles will remain sizable, but the fastest revenue expansion is shifting toward EUV and advanced ArF products.
Competitive Positioning Outlook
The market is likely to develop across three competitive groups:
Commercial EUV leaders: Mitsui Chemicals and the ASML technology ecosystem.
Emerging CNT challengers: Canatu, FST, and potentially other licensed manufacturing partners.
Established DUV specialists: Shin-Etsu Chemical, Micro Lithography, and regional conventional-pellicle manufacturers.
S&S Tech sits between the first two groups. It has direct EUV development capabilities but still needs broader commercial adoption.
Pricing will remain secondary to qualification during the early High-NA period. Semiconductor manufacturers are unlikely to change suppliers merely for a lower unit price when a pellicle failure could reduce scanner uptime or damage the economics of an expensive reticle.
Expert view: The most defensible market position will belong to suppliers that control more than the membrane. Frame engineering, inspection, mounting, scanner qualification, contamination data, and replacement support will increasingly determine customer selection.
Regional Landscape and Adoption Outlook
Demand is concentrated where advanced semiconductor fabrication, photomask production, and lithography-material infrastructure are located.
Asia Pacific represents an estimated 79.1% of global revenue in 2026. Taiwan and South Korea lead direct consumption. Japan holds a strong position in pellicle manufacturing, mask materials, and semiconductor chemicals. China contributes large DUV volumes, while export controls limit its access to the most advanced EUV ecosystem.
The United States is expected to record the strongest absolute growth outside Asia. Europe remains strategically important because it hosts ASML, imec, and Canatu, despite having a smaller share of global leading-edge wafer production.
Country and Regional Demand Outlook
| Country or Region | Estimated 2026 Revenue Share | Estimated 2026–2035 CAGR | Primary Demand Profile |
| Taiwan | 27.5% | 12.2% | Advanced foundry logic and EUV-intensive manufacturing |
| South Korea | 22.0% | 12.8% | DRAM, HBM, advanced foundry and High-NA adoption |
| Japan | 13.5% | 13.4% | Pellicle production, mask materials and new 2-nanometer capacity |
| China | 11.0% | 7.7% | High-volume DUV, mature nodes and restricted advanced-node investment |
| United States | 11.5% | 14.9% | New advanced logic and memory fabs |
| Europe | 7.0% | 11.0% | Lithography R&D, equipment and specialty semiconductor production |
| India | 0.8% | 18.0% | New DUV-oriented fabrication capacity from a small base |
| Other Markets | 6.7% | 8.5% | Specialty fabs, mask services and research demand |
The percentages are bottom-up analyst estimates based on scanner deployment, wafer-fab capacity, process-node mix, mask demand, pellicle replacement frequency, and publicly announced semiconductor investments.
Taiwan: Largest Direct Consumption Base
Taiwan is the leading market for advanced pellicle consumption due to the scale and technology position of TSMC.
The company’s manufacturing network exceeded 17 million 12-inch-equivalent wafers of annual capacity in 2025. Its Taiwan operations include six large 300-millimeter manufacturing complexes supporting logic technologies ranging from mature processes to advanced nodes.
Pellicle demand is supported by:
- Expansion of 3-nanometer production
- Ramp-up of 2-nanometer logic
- Growing AI and high-performance-computing chip volumes
- Large and frequently changing photomask libraries
- Continued use of ArF immersion alongside EUV
Taiwan is expected to remain the largest national buyer through 2035. Its market share may decline moderately as new advanced fabs open in the United States, Japan, and Europe, but absolute consumption will continue rising.
The country also has a dense network of photomask, equipment-service, material-distribution, and contamination-control companies. This reduces qualification and logistics friction.
United States: Fastest Large-Market Expansion
The United States is moving from a strong semiconductor-design and R&D base toward greater domestic advanced manufacturing.
Federal CHIPS incentives awarded up to $6.6 billion to TSMC Arizona, $7.865 billion to Intel, and $4.745 billion to Samsung Electronics. These projects support new logic and advanced-node manufacturing capacity.
The strongest pellicle demand centers will be:
- Arizona, led by TSMC and Intel
- Texas, led by Samsung Electronics
- New York and Idaho, linked to Micron Technology
- Oregon, supporting advanced process R&D
- California, supporting mask, equipment, and semiconductor-material development
The U.S. market will require both EUV and DUV products. Leading-edge fabs will create high-value EUV consumption, while supporting layers and specialty production will maintain demand for ArF and KrF pellicles.
Infrastructure is a constraint. New fabs require reliable water, electricity, skilled labor, mask services, equipment maintenance, and local inventories of highly sensitive materials.
Compared with Asia, the United States has fewer domestic pellicle-production sites. This creates opportunities for local technical-support centers, controlled storage, frame assembly, inspection, and replacement services.
Europe: Technology Leadership, Limited Direct Volume
Europe’s market position is stronger in technology than in pellicle consumption.
The region hosts:
- ASML in the Netherlands
- imec in Belgium
- Canatu in Finland
- Advanced optics and metrology companies
- Automotive, power, analog, and specialty semiconductor fabs
- New manufacturing investments in Germany and other EU countries
The ASML-imec High-NA EUV Lithography Lab opened in June 2024, giving semiconductor companies and material suppliers access to an early development platform.
In March 2026, imec received an EXE:5200 High-NA EUV system, with full qualification targeted for the fourth quarter of 2026.
Europe has also attracted around €100 billion in announced semiconductor industrial investments since the proposal of the European Chips Act.
Most new European fabs are not expected to use EUV immediately. For example, the TSMC-led Dresden facility is focused on 28/22-nanometer and 16/12-nanometer processes. This supports DUV pellicle demand rather than large direct EUV consumption.
Europe’s strongest commercial opportunity lies in:
- High-NA pellicle R&D
- CNT membrane equipment
- Scanner qualification
- Inspection and metrology
- Specialty DUV applications
- Advanced-material licensing
China: Large DUV Market, Restricted EUV Access
China possesses the world’s largest overall wafer-fabrication capacity when measured across all wafer sizes and technology generations. Chinese capacity was projected to reach 10.1 million 8-inch-equivalent wafers per month in 2025, supported by rapid investment in domestic foundries and memory production.
This makes China a substantial market for DUV pellicles. Demand is driven by:
- Mature-node foundry expansion
- Analog and power semiconductors
- Display drivers
- image sensors
- Automotive microcontrollers
- Domestic equipment and material localization
The EUV opportunity is materially constrained. U.S. controls introduced in December 2024 expanded restrictions on semiconductor manufacturing equipment, software, metrology, inspection, cleaning, and lithography-related tools used for advanced-node production.
The Netherlands also expanded national licensing requirements for advanced semiconductor manufacturing equipment in September 2024.
So, China’s market growth will remain weighted toward DUV pellicles through the forecast period. Domestic manufacturers may pursue alternative membrane materials and advanced DUV solutions, but the absence of unrestricted access to commercial EUV scanners limits near-term volume.
Expert view: China could become one of the largest pellicle markets by unit volume without becoming a leading EUV pellicle market. Mature-node capacity and repeated DUV exposure steps are sufficient to sustain a sizable commercial base.
India: High Growth From a Small Base
India represents a future DUV demand opportunity rather than an established EUV market.
The India Semiconductor Mission has a public outlay of ₹76,000 crore. By 2025, the government reported 10 approved semiconductor projects with cumulative investment of approximately ₹1.60 lakh crore across six states.
The largest planned front-end project is the Tata Electronics–PSMC fab in Dholera, Gujarat. It is designed for 50,000 wafer starts per month and involves investment of roughly ₹91,000 crore.
The initial process mix is expected to support power management, automotive, consumer, industrial, and communication chips. These applications will rely primarily on mature and specialty DUV lithography.
India’s near-term opportunities include:
- Imported DUV pellicle distribution
- Local cleanroom storage and inspection
- Photomask servicing
- Frame and assembly support
- Contamination-control consumables
- Technical partnerships with Japanese, Korean, and Taiwanese suppliers
The country lacks a domestic advanced photomask and pellicle manufacturing ecosystem at commercial scale. It also does not have a publicly confirmed EUV wafer-production program.
So, adoption will be gradual. Demand should begin with imported conventional pellicles and expand as Dholera and other manufacturing projects move into production.
Japan: Supplier Base and Emerging EUV Demand
Japan combines an established semiconductor-material industry with a renewed advanced-manufacturing strategy.
It is home to Mitsui Chemicals, Shin-Etsu Chemical, Dai Nippon Printing, and other companies involved in pellicles, photomasks, resists, mask blanks, quartz, equipment, and process chemicals.
The most important new source of EUV demand is Rapidus. Its IIM-1 facility in Hokkaido started a 2-nanometer pilot line in April 2025, with commercial manufacturing targeted for 2027. The pilot line includes more than 200 advanced manufacturing tools, including EUV lithography equipment.
Japan also installed its first NXE:3800E EUV system intended for domestic mass-production development in December 2024.
The second demand source is JASM, the TSMC-led manufacturing operation in Kumamoto. Its first fab began volume production at the end of 2024, and a second facility is under development. The combined site is planned to cover technologies ranging from mature processes to 3 nanometers.
Japan’s advantage is supply-chain depth. Local manufacturers can support membrane production, mask fabrication, inspection, resist materials, frames, and customer qualification within one national ecosystem.
South Korea: Memory and High-NA Growth Center
South Korea is the second-largest national market for advanced pellicles.
Demand is led by Samsung Electronics and SK hynix, supported by local suppliers such as FST and S&S Tech.
Samsung Foundry began mass production of its second-generation 2-nanometer GAA process in 2025. Its roadmap covers advanced logic, AI, mobile, automotive, and high-performance-computing applications.
SK hynix installed the first commercial High-NA EUV system intended for mass-production development at its M16 facility in September 2025. The equipment is being applied to future DRAM scaling and AI-memory production.
South Korea’s pellicle market benefits from three connected demand pools:
- EUV-intensive logic manufacturing
- Increasing EUV use in DRAM
- Domestic pellicle localization programs
The move toward HBM and next-generation DRAM raises lithography requirements. More advanced DRAM patterning increases the value of pellicles that protect critical reticles while maintaining scanner throughput.
South Korea may also become an export production center. The Canatu–FST licensing arrangement provides a path for locally produced CNT membranes that can serve domestic and overseas customers.
Middle East
The Middle East is not expected to become a material standalone market before 2035.
The region has growing interest in AI infrastructure, data centers, chip design, and technology investment. However, it lacks a significant commercial base of advanced photomask production, EUV lithography, and leading-edge wafer fabrication.
SEMI projections combine Europe and the Middle East and indicate rising equipment investment, but most relevant advanced manufacturing activity remains concentrated in Europe.
Any near-term Middle Eastern pellicle demand will therefore come from research laboratories, universities, small specialty facilities, and imported mask services rather than high-volume semiconductor fabs.
Expert view: Regional growth will not be determined only by the number of announced fabs. Pellicle suppliers will prioritize countries that possess an integrated combination of wafer production, mask infrastructure, scanner access, inspection systems, and qualified technical labor.
Recent Developments, Opportunities and Restraints
Recent Developments
| Year and Month | Development | Market Impact |
| May 2024 | Mitsui Chemicals announced a CNT pellicle production facility with planned capacity of 5,000 sheets annually. | Establishes dedicated commercial-scale capacity for high-power EUV and future High-NA applications. |
| December 2024 | Rapidus began installing Japan’s first NXE:3800E EUV system intended for advanced semiconductor production. | Creates a new domestic EUV customer base for pellicles, masks, inspection systems, and supporting materials. |
| September 2025 | SK hynix installed an EXE:5200B High-NA EUV system at its M16 fab. | Moves High-NA from laboratory evaluation toward commercial memory-process development. |
| October 2025 | Canatu granted Fine Semitech Corporation a commercial license to manufacture CNT pellicle membranes. | Introduces a localized reactor, consumable, and royalty-based pellicle production model. |
| March 2026 | imec received an EXE:5200 High-NA EUV system for its advanced patterning program. | Expands qualification infrastructure for pellicles, resists, masks, metrology, and High-NA processes. |
Opportunities and Business Insights
- High-power CNT pellicles
The clearest opportunity is the replacement of lower-transmission silicon membranes with CNT structures capable of supporting 600-watt to 1-kilowatt exposure environments.
A transmission increase of only a few percentage points can improve wafer throughput and reduce absorbed heat. This gives high-performance pellicles a measurable operating-cost advantage.
- Localized production and licensing
The reactor-license model may allow pellicle membranes to be manufactured near major semiconductor clusters.
This reduces transportation risk and creates recurring revenue from equipment, consumables, royalties, maintenance, and technical support.
- Inspection and predictive replacement
Defect classification, membrane-life tracking, and process monitoring represent a growing service opportunity.
Machine-vision and AI tools can compare inspection images, identify local membrane degradation, and estimate replacement timing. The value lies in preventing unplanned mask removal rather than embedding AI into the pellicle itself.
Market Restraints
Long qualification periods: New membranes must pass scanner, mask-shop, and wafer-fab testing. Commercial approval may require several development cycles.
Low manufacturing tolerance: Pinholes, wrinkles, particles, thickness variation, or weak frame attachment can make an otherwise advanced membrane unusable.
Customer concentration: A small number of leading foundries and memory companies control most EUV consumption. Losing one qualification program may materially affect a supplier’s revenue outlook.
Export controls: Restrictions on advanced lithography equipment limit the geographic market for EUV pellicles and complicate international supply-chain planning.
Cyclical capital spending: Pellicle demand is recurring, but new qualifications and installed-base expansion remain linked to semiconductor investment cycles.
Expert view: The largest commercial opportunity is not simply selling more membranes. It is lowering the total cost of protected exposure through higher transmission, longer service life, fewer mask interruptions, and faster defect detection.
“Every Organization is different and so are their requirements”- Datavagyanik
Companies We Work With


Do You Want To Boost Your Business?
drop us a line and keep in touch
